Dan Duran

Dan Duran is a seasoned executive with extensive experience in the oncology sector, currently serving as the General Manager of Navista at Cardinal Health since March 2017. In this role, Dan leads an oncology practice alliance focused on enhancing practice management and supporting community oncologists. Prior to this, Dan held significant leadership positions at Prescriptive Disruption LLC, Dendreon, and Johnson & Johnson, driving strategic initiatives in sales, marketing, and commercial operations within the pharmaceutical and biotech industries. Dan's expertise in brand marketing is highlighted by the successful launch of Zytiga, which generated $191M in its first year. Dan's career reflects a commitment to advancing patient-centered care and supporting the growth and independence of oncologists.